tiprankstipranks
Pharmaron Beijing Co., Ltd. Class H (HK:3759)
:3759
Hong Kong Market
Want to see HK:3759 full AI Analyst Report?

Pharmaron Beijing Co., Ltd. Class H (3759) Ratios

10 Followers

Pharmaron Beijing Co., Ltd. Class H Ratios

HK:3759's free cash flow for Q1 2026 was ¥0.32. For the 2026 fiscal year, HK:3759's free cash flow was decreased by ¥ and operating cash flow was ¥0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.08 0.93 1.80 2.98 1.67
Quick Ratio
0.88 0.75 1.54 2.70 1.40
Cash Ratio
0.28 0.12 0.40 1.62 0.38
Solvency Ratio
0.21 0.25 0.29 0.19 0.21
Operating Cash Flow Ratio
0.36 0.39 0.61 0.75 0.55
Short-Term Operating Cash Flow Coverage
0.62 2.55 3.37 4.77 3.23
Net Current Asset Value
¥ -2.40B¥ -3.58B¥ -2.10B¥ -2.36B¥ -3.12B
Leverage Ratios
Debt-to-Assets Ratio
0.25 0.13 0.23 0.35 0.30
Debt-to-Equity Ratio
0.43 0.23 0.41 0.75 0.58
Debt-to-Capital Ratio
0.30 0.18 0.29 0.43 0.37
Long-Term Debt-to-Capital Ratio
0.10 0.11 0.24 0.40 0.30
Financial Leverage Ratio
1.74 1.80 1.76 2.11 1.94
Debt Service Coverage Ratio
0.50 2.01 2.98 3.54 2.67
Interest Coverage Ratio
9.86 10.00 8.63 10.14 10.10
Debt to Market Cap
0.17 0.10 0.22 0.35 0.09
Interest Debt Per Share
4.05 2.05 3.24 5.38 3.54
Net Debt to EBITDA
1.64 0.73 1.14 1.17 1.83
Profitability Margins
Gross Profit Margin
34.12%34.83%34.24%35.75%36.71%
EBIT Margin
14.75%14.94%19.02%17.51%17.86%
EBITDA Margin
19.86%23.32%27.56%25.54%24.64%
Operating Profit Margin
13.61%13.68%17.14%16.02%16.46%
Pretax Profit Margin
13.51%13.57%17.04%15.93%16.23%
Net Profit Margin
11.67%11.80%14.61%13.88%13.39%
Continuous Operations Profit Margin
10.92%11.03%13.96%13.71%13.17%
Net Income Per EBT
86.33%86.99%85.75%87.12%82.49%
EBT Per EBIT
99.25%99.18%99.37%99.46%98.61%
Return on Assets (ROA)
5.93%6.14%7.49%6.05%6.71%
Return on Equity (ROE)
11.22%11.05%13.17%12.75%13.03%
Return on Capital Employed (ROCE)
9.79%10.30%10.68%8.10%10.19%
Return on Invested Capital (ROIC)
6.38%7.84%8.43%6.80%7.95%
Return on Tangible Assets
7.10%7.46%8.80%6.99%8.08%
Earnings Yield
3.45%5.37%7.58%6.30%2.43%
Efficiency Ratios
Receivables Turnover
4.45 4.31 4.05 4.38 4.64
Payables Turnover
15.22 15.14 16.92 17.98 15.99
Inventory Turnover
5.65 6.24 7.23 7.32 6.24
Fixed Asset Turnover
1.19 1.19 1.16 1.16 1.24
Asset Turnover
0.51 0.52 0.51 0.44 0.50
Working Capital Turnover Ratio
307.72 10.07 2.32 2.34 2.48
Cash Conversion Cycle
122.75 119.18 119.01 112.98 114.41
Days of Sales Outstanding
82.10 84.77 90.10 83.40 78.73
Days of Inventory Outstanding
64.63 58.50 50.49 49.88 58.50
Days of Payables Outstanding
23.97 24.10 21.57 20.30 22.83
Operating Cycle
146.73 143.28 140.58 133.28 137.23
Cash Flow Ratios
Operating Cash Flow Per Share
1.66 1.83 1.44 1.55 1.21
Free Cash Flow Per Share
0.17 0.31 0.30 -0.06 -0.46
CapEx Per Share
1.49 1.51 1.14 1.62 1.66
Free Cash Flow to Operating Cash Flow
0.10 0.17 0.21 -0.04 -0.38
Dividend Paid and CapEx Coverage Ratio
1.06 1.01 1.00 0.83 0.64
Capital Expenditure Coverage Ratio
1.11 1.21 1.26 0.96 0.73
Operating Cash Flow Coverage Ratio
0.42 0.94 0.46 0.29 0.35
Operating Cash Flow to Sales Ratio
0.21 0.23 0.21 0.24 0.21
Free Cash Flow Yield
0.75%1.78%2.26%-0.44%-1.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
28.97 18.63 13.20 15.87 41.12
Price-to-Sales (P/S) Ratio
2.77 2.20 1.93 2.20 5.51
Price-to-Book (P/B) Ratio
2.98 2.06 1.74 2.02 5.36
Price-to-Free Cash Flow (P/FCF) Ratio
133.14 56.17 44.16 -227.29 -70.03
Price-to-Operating Cash Flow Ratio
16.38 9.63 9.19 9.23 26.38
Price-to-Earnings Growth (PEG) Ratio
-3.38 -2.69 13.20 1.43 -2.09
Price-to-Fair Value
2.98 2.06 1.74 2.02 5.36
Enterprise Value Multiple
15.58 10.16 8.13 9.79 24.17
Enterprise Value
44.92B 33.40B 27.52B 28.85B 61.14B
EV to EBITDA
15.58 10.16 8.13 9.79 24.17
EV to Sales
3.09 2.37 2.24 2.50 5.96
EV to Free Cash Flow
148.78 60.52 51.35 -258.09 -75.75
EV to Operating Cash Flow
15.00 10.37 10.68 10.48 28.53
Tangible Book Value Per Share
6.88 6.22 5.97 5.45 4.15
Shareholders’ Equity Per Share
9.13 8.55 7.62 7.08 5.95
Tax and Other Ratios
Effective Tax Rate
0.19 0.19 0.18 0.14 0.19
Revenue Per Share
8.05 8.00 6.87 6.51 5.79
Net Income Per Share
0.94 0.94 1.00 0.90 0.78
Tax Burden
0.86 0.87 0.86 0.87 0.82
Interest Burden
0.92 0.91 0.90 0.91 0.91
Research & Development to Revenue
0.04 0.04 0.04 0.04 0.03
SG&A to Revenue
0.14 0.06 0.06 0.14 0.07
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.02
Income Quality
3.86 2.07 1.50 1.74 1.58
Currency in CNY